Tytuł:

Current trends in biotechnology of drugs applied in cardiovascular diseases— recombinant proteins, peptide analogues and antisense oligonucleotides

Inny tytuł:

Current trends in biotechnology of drugs applied in cardiovascular diseases— recombinant proteins, peptide analogues and antisense oligonucleotides

Twórca:

Cierniewski, Czesław S. ; Stasiak, Marta

Wydawca:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Data wydania/powstania:

1996

Temat i słowa kluczowe:

biotechnology

Abstrakt:

This lecture consists of three parts, the first one gives a summary of mechanisms regulatinghemostasis and fibrinolysis, the second — discusses potential target molecules for therapeuticintervention, and the third one describes recent studies on selective inhibition of certain pathophysiological processes by molecules designed to prevent cardiovascular problems. Thus, acritical review of current trends in biotechnology of drugs which recently have been designedand tested to improve survival of patients with different cardiovascular diseases is provided.

Czasopismo/Seria/cykl:

Biotechnologia, vol.34, 3 (1996)-.

Tom:

34

Zeszyt:

3

Strona pocz.:

11

Strona końc.:

22

Typ zasobu:

Text

Szczegółowy typ zasobu:

Article

Format:

application/pdf

Identyfikator zasobu:

0860-7796 ; IChB B-30

Źródło:

Library of Institute of Bioorganic Chemistry PAS

Język:

pol

Język streszczenia:

eng

Zakres czasowy:

1988-2010

Prawa:

Creative Commons Attribution BY-SA 4.0 license

Zasady wykorzystania:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitalizacja:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Lokalizacja oryginału:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Dofinansowane ze środków:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Dostęp:

Open